chr7-16797830-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006408.4(AGR2):c.331-136G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0675 in 641,504 control chromosomes in the GnomAD database, including 3,358 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.11   (  1929   hom.,  cov: 33) 
 Exomes 𝑓:  0.053   (  1429   hom.  ) 
Consequence
 AGR2
NM_006408.4 intron
NM_006408.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -2.52  
Publications
3 publications found 
Genes affected
 AGR2  (HGNC:328):  (anterior gradient 2, protein disulphide isomerase family member) This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal ER-signal sequence, a catalytically active thioredoxin domain, and a C-terminal ER-retention sequence. This protein plays a role in cell migration, cellular transformation and metastasis and is as a p53 inhibitor. As an ER-localized molecular chaperone, it plays a role in the folding, trafficking, and assembly of cysteine-rich transmembrane receptors and the cysteine-rich intestinal gylcoprotein mucin. This gene has been implicated in inflammatory bowel disease and cancer progression. [provided by RefSeq, Mar 2017] 
AGR2 Gene-Disease associations (from GenCC):
- respiratory infections, recurrent, and failure to thrive with or without diarrheaInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.281  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.113  AC: 17202AN: 151982Hom.:  1924  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
17202
AN: 
151982
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0532  AC: 26038AN: 489404Hom.:  1429   AF XY:  0.0508  AC XY: 13060AN XY: 257204 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
26038
AN: 
489404
Hom.: 
 AF XY: 
AC XY: 
13060
AN XY: 
257204
show subpopulations 
African (AFR) 
 AF: 
AC: 
3820
AN: 
13252
American (AMR) 
 AF: 
AC: 
1630
AN: 
19948
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
964
AN: 
14242
East Asian (EAS) 
 AF: 
AC: 
5254
AN: 
31082
South Asian (SAS) 
 AF: 
AC: 
1827
AN: 
44502
European-Finnish (FIN) 
 AF: 
AC: 
1971
AN: 
34438
Middle Eastern (MID) 
 AF: 
AC: 
119
AN: 
2278
European-Non Finnish (NFE) 
 AF: 
AC: 
8609
AN: 
302578
Other (OTH) 
 AF: 
AC: 
1844
AN: 
27084
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 1100 
 2201 
 3301 
 4402 
 5502 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 190 
 380 
 570 
 760 
 950 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.113  AC: 17244AN: 152100Hom.:  1929  Cov.: 33 AF XY:  0.113  AC XY: 8433AN XY: 74354 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
17244
AN: 
152100
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
8433
AN XY: 
74354
show subpopulations 
African (AFR) 
 AF: 
AC: 
11839
AN: 
41466
American (AMR) 
 AF: 
AC: 
1205
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
233
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
1012
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
215
AN: 
4808
European-Finnish (FIN) 
 AF: 
AC: 
582
AN: 
10582
Middle Eastern (MID) 
 AF: 
AC: 
20
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1939
AN: 
68012
Other (OTH) 
 AF: 
AC: 
199
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 697 
 1394 
 2091 
 2788 
 3485 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 166 
 332 
 498 
 664 
 830 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
465
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.